sulforaphane has been researched along with Lupus Nephritis in 2 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Lupus Nephritis: Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A murine lupus nephritis model using Nrf2(+/+) and Nrf2(-/-) mice was established using pristine injection." | 1.40 | Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response. ( Jiang, T; Lin, Y; Tian, F; Whitman, SA; Zhang, DD; Zhang, N; Zhang, Z; Zheng, H, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, T | 1 |
| Tian, F | 1 |
| Zheng, H | 1 |
| Whitman, SA | 1 |
| Lin, Y | 1 |
| Zhang, Z | 1 |
| Zhang, N | 1 |
| Zhang, DD | 1 |
| Ebihara, S | 1 |
| Tajima, H | 1 |
| Ono, M | 1 |
2 other studies available for sulforaphane and Lupus Nephritis
| Article | Year |
|---|---|
Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response.
Topics: Adult; Animals; Antibodies, Monoclonal; Case-Control Studies; Cells, Cultured; Disease Models, Anima | 2014 |
Nuclear factor erythroid 2-related factor 2 is a critical target for the treatment of glucocorticoid-resistant lupus nephritis.
Topics: Animals; Anti-Inflammatory Agents; Dimethyl Fumarate; Disease Models, Animal; Drug Resistance; Enzym | 2016 |